These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15692986

  • 1. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [Abstract] [Full Text] [Related]

  • 2. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I, Burgos-Vargas R, Thon A, Tuerck D.
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [Abstract] [Full Text] [Related]

  • 3. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
    Lovell DJ, Dare JA, Francis-Sedlak M, Ball J, LaMoreaux BD, Von Scheven E, Reinhardt A, Jerath R, Alpan O, Gupta R, Goldsmith D, Zeft A, Naddaf H, Gottlieb B, Jung L, Holt RJ.
    Pediatr Rheumatol Online J; 2018 Jun 26; 16(1):41. PubMed ID: 29941047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S, Hall DB, Roszko PJ, Meloxicam Rheumatoid Arthritis Investigators.
    J Rheumatol; 2002 Mar 26; 29(3):436-46. PubMed ID: 11908554
    [Abstract] [Full Text] [Related]

  • 7. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.
    Hanft G, Türck D, Scheuerer S, Sigmund R.
    Inflamm Res; 2001 Mar 26; 50 Suppl 1():S35-7. PubMed ID: 11339520
    [Abstract] [Full Text] [Related]

  • 8. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
    Hosie J, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 26; 35 Suppl 1():39-43. PubMed ID: 8630635
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
    Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P.
    Arch Intern Med; 2000 Oct 23; 160(19):2947-54. PubMed ID: 11041902
    [Abstract] [Full Text] [Related]

  • 10. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B, Vélicitat P, Garzón N, Bluhmki E.
    Inflamm Res; 2001 Mar 23; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [Abstract] [Full Text] [Related]

  • 11. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
    Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N, JUVE-BASIS investigators, Paediatric Rheumatology International Trials Organisation.
    Lancet; 2023 Aug 12; 402(10401):555-570. PubMed ID: 37423231
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
    Lovell DJ, Giannini EH, Reiff AO, Kimura Y, Li S, Hashkes PJ, Wallace CA, Onel KB, Foell D, Wu R, Biedermann S, Hamilton JD, Radin AR.
    Arthritis Rheum; 2013 Sep 12; 65(9):2486-96. PubMed ID: 23754188
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM, Bolten W, Burgos-Vargas R, Platt P, Nissilä M, Sahlberg D, Björneboe O, Baumgartner H, Valat JP, Franchimont P, Bluhmki E, Hanft G, Distel M.
    J Rheumatol; 1997 Feb 12; 24(2):282-90. PubMed ID: 9034984
    [Abstract] [Full Text] [Related]

  • 14. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ.
    J Rheumatol; 2009 Jan 12; 36(1):174-82. PubMed ID: 19012356
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
    Lund B, Distel M, Bluhmki E.
    Scand J Rheumatol; 1998 Jan 12; 27(1):32-7. PubMed ID: 9506875
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis.
    Reginster JY, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 12; 35 Suppl 1():17-21. PubMed ID: 8630631
    [Abstract] [Full Text] [Related]

  • 17. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
    Jesam C, Salvatierra AM, Schwartz JL, Fuentes A, Croxatto HB.
    Contraception; 2014 Aug 12; 90(2):168-73. PubMed ID: 24909636
    [Abstract] [Full Text] [Related]

  • 18. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
    Singh G, Lanes S, Triadafilopoulos G.
    Am J Med; 2004 Jul 15; 117(2):100-6. PubMed ID: 15234645
    [Abstract] [Full Text] [Related]

  • 19. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 15; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 20. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
    Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhães C, Sztajnbok F, Goldenstein-Schainberg C, Scheinberg M, Penades IC, Fischbach M, Orozco J, Hashkes PJ, Hom C, Jung L, Lepore L, Oliveira S, Wallace CA, Sigal LH, Block AJ, Covucci A, Martini A, Giannini EH, Paediatric Rheumatology INternational Trials Organization, Pediatric Rheumatology Collaborative Study Group.
    Lancet; 2008 Aug 02; 372(9636):383-91. PubMed ID: 18632147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.